A recent article on marketwatch.com reported that German healthcare group Fresenius had solid first-half results and expected continued strong growth. The company
Continue Reading →
A 2012 article in the New York Times reported that the FDA is investigating whether or not Fresenius violated any federal laws by failing to warn patients of a potentially lethal risk linked to one of its drugs. An internal memo
Continue Reading →
Dialysis Lawsuits
Fresenius 2Q Profit Rises 35%
A recent article on marketwatch.com reported that German healthcare group Fresenius had solid first-half results and expected continued strong growth. The company
Continue Reading →Company’s Failure to Warn of Product Risk Draws Inquiry
A 2012 article in the New York Times reported that the FDA is investigating whether or not Fresenius violated any federal laws by failing to warn patients of a potentially lethal risk linked to one of its drugs. An internal memo
Continue Reading →